Advocates worried that the resignation of FDA Commissioner Scott Gottlieb's could reverse progress on public health issues like vaping.
Sarah Johnson/Flickr
FDA Commissioner Scott Gottlieb told Business Insider he is"100% certain" that it will be settled before he leaves the job in a few weeks. Gottlieb gave notice this month that he's resigning to spend more time with his family. The US Food and Drug Administration will soon announce broad restrictions on where flavored e-cigarettes are sold, in an effort to prevent young people from taking up vaping.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Health advocates worry about an FDA without Scott GottliebWith Scott Gottlieb leaving the FDA, public health advocates worry that some of his public health goals will go unfinished.
Lire la suite »
FDA allows genetically engineered 'Frankenfish' salmon to be imported to USAmericans are one step closer to seeing genetically modified salmon at their grocery stores.
Lire la suite »
Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Lire la suite »
Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Lire la suite »
FDA chief Gottlieb's departure might not actually be a good thing for vaping industrySome have called FDA Commissioner Scott Gottlieb's resignation a boon for the e-cigarette industry. It may prove more complicated.
Lire la suite »
National Cancer Institute Director Ned Sharpless will be acting FDA commissionerNational Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
Lire la suite »
Altria shares hit after National Cancer Institute director named acting head of the FDAAltria investors don't seem to like the prospects for the cigarette maker under the new acting FDA commissioner.
Lire la suite »
Biotech shares continue to fall on FDA uncertaintyThe biotech sector is on pace for its worst weekly decline since December, weighed down in part by uncertainty following this week's surprise announcement from FDA chief Scott Gottlieb that he will be stepping down next month.
Lire la suite »
Biotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent.
Lire la suite »
Nation’s cancer chief appointed acting FDA commissionerNorman 'Ned' Sharpless has been named acting head of the Food and Drug Administration.
Lire la suite »